EDGAR Filing Documents for 0001144204-19-030119

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-19-030119

Filing Date

2019-06-06

Accepted

2019-06-06 17:15:53

Documents

Period of Report

2019-06-06

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tv523232_6-k.htm	6-K	10813
2	EXHIBIT 99.1	tv523232_ex99-1.htm	EX-99.1	707773
3	GRAPHIC	tv523232_img01.jpg	GRAPHIC	103871
	Complete submission text file	0001144204-19-030119.txt		862991

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 19883354
SIC: 2834 Pharmaceutical Preparations